Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IVIG for autoimmune encephalitis in adults
ISRCTN69615004Phase 3Completed
- Sponsor
- University of Liverpool
- Start
- Nov 2021
- Modality
- Recombinant Proteins and Enzymes
01
Overview
Phase 3, randomised, double-blind trial in Autoimmune Encephalitis (AE) comparing IVIG plus corticosteroids with Placebo plus corticosteroids (2 arms). Primary endpoint: Recovery over 12 months by Glasgow Outcome Scale-Extended. Started Nov 2021; status: completed.
02
Drugs
immune globulin
03
Conditions
Autoimmune Encephalitis (AE)
Beyond the preview
Go deeper on ISRCTN69615004.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN69615004.